Baird Financial Group Inc. Purchases 5,447 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• Baird Financial Group Inc. increased its stake in GE HealthCare Technologies by 3.1%, acquiring 5,447 additional shares during the first quarter, bringing its total holdings to 183,226 shares valued at approximately $14.8 million.
• Wall Street analysts have a favorable outlook for GE HealthCare Technologies, with eight analysts rating it "buy" and one "strong buy", along with an average target price of $88.55.
• GE HealthCare Technologies reported a quarterly EPS of $1.06, exceeding expectations, and increased revenue by 3.5% year-over-year, with FY 2025 guidance set at 4.430-4.630 EPS.

Baird Financial Group Inc. lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 183,226 shares of the company's stock after purchasing an additional 5,447 shares during the period. Baird Financial Group Inc.'s holdings in GE HealthCare Technologies were worth $14,788,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. N.E.W. Advisory Services LLC bought a new position in shares of GE HealthCare Technologies in the 1st quarter worth $25,000. Bogart Wealth LLC raised its stake in GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after buying an additional 247 shares during the period. Stonebridge Financial Group LLC raised its stake in GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after buying an additional 222 shares during the period. Ameriflex Group Inc. acquired a new stake in GE HealthCare Technologies during the 4th quarter worth $31,000. Finally, Olde Wealth Management LLC acquired a new stake in GE HealthCare Technologies during the 1st quarter worth $35,000. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently commented on GEHC shares. Citigroup raised their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. BTIG Research reaffirmed a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Finally, Morgan Stanley dropped their price objective on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $88.55.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded up $1.61 during midday trading on Friday, reaching $75.73. 3,009,491 shares of the company's stock were exchanged, compared to its average volume of 2,651,304. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The firm has a market cap of $34.58 billion, a price-to-earnings ratio of 15.52, a P/E/G ratio of 2.89 and a beta of 1.13. The stock's 50-day simple moving average is $74.28 and its 200 day simple moving average is $74.02.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same quarter last year, the company posted $1.00 earnings per share. GE HealthCare Technologies's quarterly revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's payout ratio is currently 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.